| Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T-lymphotropic virus type 1 infection H Kagdi, MA Demontis, JC Ramos, GP Taylor PLoS pathogens 14 (2), e1006861, 2018 | 39 | 2018 |
| Risk stratification of adult T‐cell leukemia/lymphoma using immunophenotyping HH Kagdi, MA Demontis, PA Fields, JC Ramos, CRM Bangham, ... Cancer medicine 6 (1), 298-309, 2017 | 30 | 2017 |
| Immune compromise in HIV-1/HTLV-1 coinfection with paradoxical resolution of CD4 lymphocytosis during antiretroviral therapy: a case report N Rockwood, L Cook, H Kagdi, S Basnayake, CRM Bangham, ... Medicine 94 (50), e2275, 2015 | 19 | 2015 |
| Decreased RORC expression and downstream signaling in HTLV‐1‐associated adult T‐cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for … K Subramanian, T Dierckx, R Khouri, SM Menezes, H Kagdi, GP Taylor, ... International Journal of Cancer 144 (7), 1664-1675, 2019 | 17 | 2019 |
| A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and … TA Eyre, G Preston, H Kagdi, A Islam, T Nicholson, HW Smith, AP Cursley, ... British Journal of Haematology 194 (1), 69-77, 2021 | 16 | 2021 |
| Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single‐centre experience of 19 years. G Ling, H Kagdi, B Subel, P Chowdary, K Gomez Haemophilia 22 (3), 411-418, 2016 | 15 | 2016 |
| Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naïve chronic lymphocytic leukaemia: a case report. G Nesr, R Koshy, D Foldes, H Kagdi | 12 | 2020 |
| Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom C Garnett, D Foldes, C Bailey, G Nesr, T Hui, R Hinton, K Gurung, ... Leukemia & Lymphoma 62 (2), 469-472, 2021 | 8 | 2021 |
| combination therapy with proteasome inhibitor Bortezomib and humanized anti-CD25 Basiliximab for treatment of adult T cell leukaemia lymphoma H Kagdi, P Fields, A Hodson, G Taylor Retrovirology 11 (Suppl 1), P8, 2014 | 3 | 2014 |
| CD25+ CCR4+ cells as a marker of HTLV-1-infected cells in peripheral blood H Kagdi, A Melamed, S Hilburn, MA Demontis, C Bangham, G Taylor Retrovirology 11, 1-1, 2014 | 2 | 2014 |
| Plasma cell leukaemia with" lymphoid‐like morphology" in peripheral blood. G Nesr, R Maniusyte, A Dunlop, H Kagdi International Journal of Laboratory Hematology 44 (1), 2022 | 1 | 2022 |
| Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust R Hinton, G Nesr, C Garnett, D Foldes, JJR McCay, R Medland, H Kagdi, ... Leukemia & Lymphoma 63 (1), 227-230, 2022 | 1 | 2022 |
| A Multicentre, Retrospective Observational Study to Evaluate the Clinical Outcomes of Patients with Chronic Lymphocytic Leukaemia (CLL) Treated with Idelalisib and Rituximab in … TA Eyre, G Preston, HH Kagdi, A Islam, T Nicholson, C Fegan, HW Smith, ... Blood 134, 1762, 2019 | 1 | 2019 |
| Transcriptome and Somatic Mutation Associated with Non-Malignant Human T Lymphotropic Virus Type 1 Infection and Adult T-Cell Leukemia/Lymphoma HH Kagdi, GP Taylor Blood 132, 2843, 2018 | 1 | 2018 |
| The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma H Kagdi, A Melamed, S Hilburn, N Gillet, A Hodson, MA Demontis, ... Retrovirology 11, 1-1, 2014 | 1 | 2014 |
| The In Vivo infected Clones Have Mixed Immunophenotype and Malignant Transformation Is Characterized By Dominant Growth of CD4+ CCR4+ CD26-CD7-Cells in Human T Lymphotropic … HH Kagdi, GP Taylor Blood 132, 2844, 2018 | | 2018 |
| The molecular and phenotypic signature of human T-cell lymphotropic virus type 1 infected clones and their malignant potential HH Kagdi Imperial College London, 2018 | | 2018 |
| CD8 malignant proliferation in association with human T cell lymphotropic Virus 1 infection: a case report H Kagdi, A Rowan, F Child, E Calonje, M Moomin, MA Demontis, ... Retrovirology 12, 1-1, 2015 | | 2015 |
| Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma H Kagdi, A Rowan, MA Demontis, C Bangham, G Taylor Retrovirology 12, 1-1, 2015 | | 2015 |
| Safe use of FXI concentrate in a single centre experience over 19 years G Ling, H Kagdi, P Chowdary, K Gomez JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13, 437-437, 2015 | | 2015 |
